News

Deal Announcements

DNAnexus Closes $15 Million Series B

Thursday, October 13, 2011 5:58:00 AM PDT | VentureDeal Staff
   Palo Alto, California  --  Biotechnology company DNAnexus has received $15 million in its second round of institutional venture capital investment.

DNAnexus is creating next-generation DNA sequencing technologies that aims to provide personal genomic identification for better cancer treatments.

TPG Biotech and Google Ventures led the round, which also included SoftTech VC, K9 Ventures, First Round Capital and Felicis Ventures.

The company said it would use the financing to continue product development and hire additional employees.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1